Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Clinical trial NCT04858425 · TERMINATED
Trial details
- NCT number
- NCT04858425
- Sponsor
- Entero Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-06-04
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.